A Neuroendocrine Differentiation-related Molecular Model for Prognosis Prediction in Prostate Cancer Patients
This research developed a unique neuroendocrine differentiation-related molecular model that is highly suitable for predicting BCR-free survival (BCRFS). High DMBX1 expression may promote the development and neuroendocrine differentiation of prostate cancer.
Authors
- Xue‐Yi Xue (ORCID: https://orcid.org/0000-0002-6461-7435)
- Qing‐Shui Zheng (ORCID: https://orcid.org/0000-0002-7426-6501)
- Ning Xu (ORCID: https://orcid.org/0000-0001-7909-7025)
- Qian-Ren-Shun Qiu
- Yong Wei (ORCID: https://orcid.org/0000-0001-5324-3733)
- Jiang‐Bo Sun
- Xiong‐Lin Sun
- Yuxuan Zhao (ORCID: https://orcid.org/0000-0003-3182-8479)
Institutions
- Fujian Medical University (CN)
- First Affiliated Hospital of Fujian Medical University (CN)
Publication Details
- Journal
- Current Medicinal Chemistry
- Published
- 2025-05-15
- DOI
- https://doi.org/10.2174/0109298673362568250505074520
- Citations
- 1
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.05